The global “Contact Lenses Market Size” is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.
Highlights of the Report:
- In-depth analysis of various insights, namely, Contact Lenses Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Contact Lenses Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contact-lenses-market-101775
Key Players Operating in The Contact Lenses Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Contamac
- CooperVision
- HOYA Corporation
- Essilor
- Bausch & Lomb Incorporated
- Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
- ZEISS International
- Alcon Vision LLC
- Other key market players
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775
Rising Prevalence of Ocular Disorders to Augment Market Growth
The World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world. A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years. Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.
Asia Pacific to Exhibit Rapid Growth Fueled by Rising Disposable Income
The contact lenses market can be geographically grouped into the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. Out of them, North America is set to dominate the market during the forecast period. It was valued at USD 2.75 billion in 2018. This growth is attributed to the rising usage of contact lenses amongst the masses as well as increasing prevalence of presbyopia. The Centers for Disease Control and Prevention (CDC) mentioned that in the U.S., around 45 million people use contact lenses.
Asia Pacific, on the other hand, is expected to remain in the second position owing to gradual inclination of the masses to disposable contact lenses from reusable contact lenses. Also, various market players are launching novel products day by day in this region. It is also giving rise to market growth. The region is projected to experience rapid growth in the coming years owing to the rising trend of wearing contact lenses amongst the youngsters for correcting vision errors. Moreover, the increasing awareness programs regarding the benefits of using contact lenses, rising disposable income, and availability of lenses on online platforms would also contribute to the demand for contact lenses in this region.
Knee replacement is a surgical procedure that minimizes pain and enhances the quality of life in patients with severe arthritis.
Furthermore, increasing penetration of pain treatments in cases of age-related joint disorders and other complications due to co-occurring diseases, such as diabetes and obesity, will drive the knee replacement industry.
According to Renub Research Analysis, Global Knee Replacement Market is expected to value more than US$ 12.87 Billion by the end of the year 2027.
Gender wise women account for a major share as patients since increased incidences of osteoarthritis and osteoporosis are more common in aged women.
In North America, the increasing demand for the young and active population is the main factor propelling the growth of the knee replacement industry.
In 2021, Zimmer Biomet Holdings, Inc., announced the ROSA® Partial Knee System for robotically-assisted partial knee replacement surgeries.
The global tetanus toxoid vaccine market is expected to reach USD 7.16 Billion by 2028, according to a new report by Reports and Data.
This can mainly be contributed by the rise in number of reported cases of tetanus and diphtheria in the developing countries.
The low costs of the vaccine, as well as the increasing government initiatives towards technological improvements regarding immunization and vaccination, are also fuelling the growth of the market.Several vaccine combinations include the tetanus vaccine such as Diphtheria, Tetanus, and Pertussis (DTaP); Monovalent Tetanus Toxoid (TT); Tetanus, Diphtheria, And Pertussis (Tdap); Diphtheria and Tetanus (DT); and others.
DTaP and DT are used as a pediatric vaccine for children less than seven years old while Tdap and Td are given to those who are seven years old and above, where the lowercase, ‘d’ and ‘p’ denote the lower strengths of diphtheria and pertussis vaccines.The primary factors for the market growth are most active, less expensive and best-tolerated vaccines.
The acquisition of tetanus vaccination by the UNICEF, WHO and other government initiatives for the prevention and treatment of tetanus are expected to act as opportunities for the global market.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1287 The report provides a panoramic view of the market and insights that will help formulate better business decisions.
In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions.
The global contact lenses market is expected to rise with an impressive CAGR and generate the highest revenue by 2026.
Fortune Business Insights™ in its latest report published this information.
The report is titled "Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmlogists), and Regional Forecast, 2019-2026".
The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period.
It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.View press release for more information@ https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration.
The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other contact lenses market trends.
The global Cardiac Biomarkers market was valued at USD 7.96 Billion in 2020 and is expected to reach USD 17.55 Billion by year 2028, at a CAGR of 10.4%.According to the Centre for Disease Control and Prevention (CDC), for around 610,000 people die of heart disease in United States every year, that’s 1 in every 4 deaths and more than half of the deaths due to heart disease were in men.
Cardiac biomarkers are protein-based observable materials discharged into blood when the heart’s muscles are wounded which can be used as risk stratification for numerous cardiovascular diseases (CVDs) that includes Acute Myocardial Infarction (AMI), Ischemia, Congestive Heart Failure (CHF), Acute Coronary Syndrome (ACS) and others related with insufficient blood flow to heart.The high occurrence rates of CVDs worldwide and the growing demand for POC cardiac testing kits are expected to fuel the market growth.
Certain manufacturing, limited specificity and pharmacological issues and regulatory hurdles are hindering the growth of the market.Top Companies Profiled in the Report Include:Abbott Laboratories, Alere Inc. and Roche Diagnostics Corporation.Get a sample of the report @ URL https://www.reportsanddata.com/sample-enquiry-form/1422Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level.
In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities.
Request a discount on the report @ URL https://www.reportsanddata.com/discount-enquiry-form/1422The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R activities, and government and corporate deals, among others through extensive primary and secondary research.
